These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25840417)

  • 1. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
    Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
    Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
    Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
    Lu KK; Trcka D; Bendeck MP
    Cardiovasc Pathol; 2011; 20(2):71-6. PubMed ID: 20093046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.
    Avino S; De Marco P; Cirillo F; Santolla MF; De Francesco EM; Perri MG; Rigiracciolo D; Dolce V; Belfiore A; Maggiolini M; Lappano R; Vivacqua A
    Oncotarget; 2016 Aug; 7(33):52710-52728. PubMed ID: 27384677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
    Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
    Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
    Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
    Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.
    Hou G; Vogel W; Bendeck MP
    J Clin Invest; 2001 Mar; 107(6):727-35. PubMed ID: 11254672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1.
    Hansen C; Greengard P; Nairn AC; Andersson T; Vogel WF
    Exp Cell Res; 2006 Dec; 312(20):4011-8. PubMed ID: 17027969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
    Vella V; Giuliano M; Nicolosi ML; Majorana MG; Marć MA; Muoio MG; Morrione A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
    Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
    Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea.
    Mohan RR; Mohan RR; Wilson SE
    Exp Eye Res; 2001 Jan; 72(1):87-92. PubMed ID: 11133186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
    Vella V; Malaguarnera R
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.
    Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL
    Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
    An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
    Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis.
    Kaulfuss S; Burfeind P; Gaedcke J; Scharf JG
    Mol Cancer Ther; 2009 Apr; 8(4):821-33. PubMed ID: 19372555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen I regulates the self-renewal of mouse embryonic stem cells through α2β1 integrin- and DDR1-dependent Bmi-1.
    Suh HN; Han HJ
    J Cell Physiol; 2011 Dec; 226(12):3422-32. PubMed ID: 21344393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.
    Sabbatini P; Rowand JL; Groy A; Korenchuk S; Liu Q; Atkins C; Dumble M; Yang J; Anderson K; Wilson BJ; Emmitte KA; Rabindran SK; Kumar R
    Clin Cancer Res; 2009 May; 15(9):3058-67. PubMed ID: 19383820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of Src tyrosine kinase.
    Slack BE; Siniaia MS; Blusztajn JK
    J Cell Biochem; 2006 Jun; 98(3):672-84. PubMed ID: 16440311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.